Monthly Archives: October 2017

We have explored associations for screen-detected gallstone disease and cancer in a Danish general population cohort and identified associations for gallstone disease and incident gastrointestinal cancer, especially for right-side colon cancer.1 Based … Continue reading →

Outcomes of liver transplantation for hepatocellular carcinoma (HCC) are determined by cancer-related and non-related events. Treatments for hepatitis C virus (HCV) infection have reduced non-cancer events among patients receiving liver transplants, so… Continue reading →

We read with interest the Matsuura et al1 genome-wide association study (GWAS) of 456 Japanese patients identifying tolloid like 1 (TLL1) as a novel susceptibility locus for hepatocellular carcinoma (HCC) after clearance of hepatitis C virus (HCV) wit… Continue reading →

Question: A 66-year-old woman came to our hospital complaining of dysphagia for 1 month. She denied a family history of gastrointestinal carcinoma and a history of previous surgery. Remarkable previous history of bronchiectasis in the past years and oc… Continue reading →

In their recently published meta-analysis, Shen et al1 found that early administration of probiotics decreased the incidence of Clostridium difficile infection after antibiotic treatment. Shen et al wisely recall that the use of probiotics should be … Continue reading →

The purpose of this review is to describe a place for per-oral endoscopic myotomy (POEM) among the currently available robust treatments for achalasia.The recommendations outlined in this review are based on expert opinion and on relevant publications … Continue reading →